OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr Ricardo Fernandes is a Group Leader at the CAMS Oxford Institute and Nuffield Department of Medicine at the University of Oxford. He holds a PhD from Oxford, where he worked with Simon Davis to elucidate the mechanism of TCR triggering. Later, he moved to Stanford, where he developed innovative bispecific proteins that utilize endogenous membrane phosphatases to inhibit signalling by surface receptors found in T cells. The Fernandes’ Lab focuses on elucidating the functional and structural aspects of immune receptor signalling and identifying novel therapeutic strategies for modulating T cell function in the context of autoimmunity and cancer.
